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Abstract 
Background: Prenatal exposure to Plasmodium falciparum affects development of protective immunity and sus-
ceptibility to subsequent natural challenges with similar parasite antigens. However, the nature of these effects has 
not been fully elucidated. The aim of this study was to determine the effect of prenatal exposure to P. falciparum on 
susceptibility to natural malaria infection, with a focus on median time from birth to first clinical malaria episode and 
frequency of clinical malaria episodes in the first 2 years of life.
Methods: A prospective birth cohort study was conducted in Rufiji district in Tanzania, between January 2013 
and December 2015. Infants born to mothers with P. falciparum in the placenta at time of delivery were defined as 
exposed, and infants born to mothers without P. falciparum parasites in placenta were defined as unexposed. Placen-
tal infection was established by histological techniques. Out of 206 infants recruited, 41 were in utero exposed to P. 
falciparum and 165 infants were unexposed. All infants were monitored for onset of clinical malaria episodes in the 
first 2 years of life. The outcome measure was time from birth to first clinical malaria episode, defined by fever (≥37 °C) 
and microscopically determined parasitaemia. Median time to first clinical malaria episode between exposed and 
unexposed infants was assessed using Kaplan–Meier survival analysis and comparison was done by log rank. Associa-
tion of clinical malaria episodes with prenatal exposure to P. falciparum was assessed by multivariate binary logistic 
regression. Comparative analysis of mean number of clinical malaria episodes between exposed and unexposed 
infants was done using independent sample t test.
Results: The effect of prenatal exposure to P. falciparum infection on clinical malaria episodes was statistically signifi-
cant (Odds Ratio of 4.79, 95 % CI 2.21–10.38, p < 0.01) when compared to other confounding factors. Median time 
from birth to first clinical malaria episode for exposed and unexposed infants was 32 weeks (95 % CI 30.88–33.12) 
and 37 weeks (95 % CI 35.25–38.75), respectively, and the difference was statistically significant (p = 0.003). The mean 
number of clinical malaria episodes in exposed and unexposed infants was 0.51 and 0.30 episodes/infant, respec-
tively, and the difference was statistically significant (p = 0.038).
Conclusions: Prenatal exposure to P. falciparum shortens time from birth to first clinical malaria episode and 
increases frequency of clinical malaria episodes in the first 2 years of life.
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Background
Sub-Saharan Africa still faces high rates of infant mor-
tality due to Plasmodium falciparum infections, despite 
strategies put in place for the control of malaria [1]. In 
Tanzania, where this study was conducted, more than 
80  % of the malaria infections are linked to P. falcipa-
rum [2]. It has been demonstrated that malaria due to 
P. falciparum during pregnancy may affect newborn 
susceptibility to subsequent malaria infections, and 
that infants born to mothers with placental malaria 
are exposed in utero to P. falciparum antigens [3–7]. 
The effect of early exposure to P. falciparum antigen on 
development of infant protective immunity has been 
studied and in utero exposed infants have been reported 
to have limited protective immune response to subse-
quent natural challenges with the same parasite antigen 
[8–10]. Epidemiological studies in some endemic areas 
have consistently demonstrated differences between 
children born to mothers with placental malaria (pm+) 
and those born to mothers without placental malaria 
(pm−).
A study conducted in Cameroon demonstrated that the 
prevalence of malaria parasitaemia in infants aged four 
to 6 months was higher in those born to pm+ mothers 
compared to the controls [11], while a study in Malawi 
demonstrated that the risk of mortality due to malaria 
was higher in infants born to pm+ mothers compared to 
those born to pm− mothers [12]. Although it has been 
established that prenatal exposure to malaria parasites 
influences the subsequent susceptibility of infants to 
malaria infection, there are other factors that may influ-
ence susceptibility to early malaria infections. The identi-
fied factors include but not limited to age of the mother, 
use of intermittent preventive treatment during preg-
nancy, gravidity and season of birth may influence the 
degree of exposure to malaria infection [13]. The dearth 
of information on the compounded effect of other factors 
and prenatal sensitization to the parasite antigens and 
their effects on subsequent susceptibility to the natural 
challenge of P. falciparum infection indicate that there 
remains a need to characterize this phenomenon.
This study was designed to systematically and prospec-
tively follow up a birth cohort of infants for a period of 
2 years, to delineate the effects of prenatal exposure to P. 
falciparum antigens and other factors (gravidity, season 
of birth, age of the mother, and infant birth weight) that 
could influence susceptibility, with respect to frequency 
and time from birth to first clinical malaria episode in 
infants born to pm+ and pm− mothers.
Methods
Study area
Four public health facilities (Utete, Mohoro Ikwiriri and 
Kibiti) located in Rufiji District, Coast Region in Tan-
zania were involved in this study. The area is low-lying, 
below 500 m above sea level and most of its surface area 
lies within the fertile flood plain of Rufiji River. Rufiji dis-
trict typically experiences a long rainy season between 
February and May and a shorter, less intense one from 
October to December. Annual rainfall ranges between 
800 and 1000  mm in the Rufiji River basin and malaria 
transmission occurs all year round.
Study design, study population and recruitment 
of research participants
This was a prospective birth cohort study which included 
206 mother infant pairs with infants aged 0–24 months. 
The criteria for recruitment of mothers included HIV 
seronegativity (pregnant mothers are routinely screened 
for HIV during prenatal visits in the study area) and 
confirmation to stay within the study area for a period 
of 2 years to facilitate follow up of infants to the age of 
2 years. In order to maintain confidentiality, all study par-
ticipants were assigned code numbers. The group assign-
ment of the study participants was based on placental 
malaria status established by examination of placental 
tissues using histological techniques. Histological classi-
fication was not done in this study but the presence or 
absence of P. falciparum in the placenta at the time of 
delivery confirmed by histopathology was used to catego-
rize the mothers and their infants. Mothers who had P. 
falciparum in their placenta at time of delivery confirmed 
by histopathology were defined as placental malaria posi-
tive (pm+) and their infants were defined as exposed to 
P. falciparum, while mothers who had no P. falciparum 
infection at time of delivery were defined as placental 
malaria negative (pm−) and their infants were defined as 
unexposed.
Placental tissue collection, storage and histopathological 
examination
In order to establish placental malaria infection histologi-
cal samples were collected and processed. Briefly, follow-
ing delivery, the maternal side of placenta was placed in 
an upright position and cleaned with sterile normal saline 
and a health paracentric area was then incised. Mater-
nal placental tissue was examined using histopathologic 
techniques as previously described [14]. A full thickness 
of placental biopsy (8  cm3) was collected, by a trained 
Keywords: Prenatal exposure, Plasmodium falciparum, Clinical malaria episode, Newborns, Susceptibility
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and experienced nurse, from the maternal surface half-
way between the placental edge and the insertion of the 
umbilical cord, within 4 hours of placental expulsion. The 
placental tissue was fixed in 10 % neutral-buffered forma-
lin. Following fixation, placental tissue was trimmed and 
placed into histopathological cassettes, processed on an 
automated tissue processor overnight, embedded in par-
affin wax, and then sectioned on a microtome to obtain 
5-nm slices. The slices were placed in warm water bath at 
about 56 °C and transferred onto a microscope slide and 
left to dry and adhere to the slide. The placental sections 
were stained using haematoxylin and eosin and were then 
examined using light microscopic technique. Results 
were reported as placental malaria positive (Fig. 1) or pla-
cental malaria negative.
Examination of placental blood specimen using a light 
microscope
Using fresh placental blood specimen, thin smears were 
prepared, dried and fixed in methyl alcohol. Thick smears 
were not subjected to any fixative but dried and stained 
with 10  % working Giemsa for 10  min, washed, dried, 
and kept in slide boxes for microscopic examination. All 
smears were read independently by two trained labora-
tory technologists and discordant results on malaria spe-
cies and parasite count were resolved by the Investigator. 
Results were reported as positive or negative for P. falci-
parum (Fig. 2). Documentation by photograph was done 
using Leica microsystem for future reference.
Follow up of recruited infants and determination of clinical 
malaria episodes
Recruited infants were followed-up both at community 
and facility levels by trained research assistants. Sched-
uled visits were conducted regularly at 3 months intervals 
for a period of 2 years from birth while unscheduled vis-
its were conducted whenever recruited infants had signs/
symptoms of illness. Clinical examination was conducted 
by a trained study physician and clinical signs/symptoms 
were recorded on designated follow up questionnaire 
forms. Blood smears were collected for determination 
of clinical malaria infection using light microcopy tech-
nique. Clinical malaria was defined as fever (≥37.5  °C) 
with microscopically determined parasitaemia. Following 
the initial malaria episode, a new clinical malaria infec-
tion was defined as presence of asexual P. falciparum 
parasites in blood with fever (≥37.5 °C) after a period of 
2  weeks or beyond from the previously treated clinical 
malaria episode. All Infants who were diagnosed of clini-
cal malaria infection were treated within the routine sys-
tem at the health facilities. In addition, infants who were 
diagnosed of non-malaria diseases were attended and 
provided with standard medical care during the entire 
study period.
Time to first clinical malaria episode was determined 
in all recruited infants in order to assess the vulner-
ability to malaria infection. Specific birth dates for the 
recruited infants and dates when they experienced clini-
cal malaria episode for the first time were systematically 
recorded. Time elapsed from birth to diagnosis of clini-
cal malaria episode was defined as the time to first clini-
cal malaria episode. This was recorded for each recruited 
infant in weeks and the median time for each group was 
determined. Subsequent malaria episodes experienced 
by recruited infants were also recorded on the designed 
forms to determine the frequency of clinical malaria epi-
sodes during the first 24 months of life.
Data management and analysis
Double-entry system was employed in data entry pro-
cess. The data were cleaned and analysed using the 
Fig. 1 Demonstration of Plasmodium falciparum in intervillous 
erythrocytes in histological section of placenta stained using haema-
toxylin and eosin. 100× magnification. The section demonstrates P. 
falciparum in intervillous erythrocytes. An arrow is pointing at one of 
the parasitized (P.falciparum) intervillous red blood cell
Fig. 2 Thin blood smear prepared from placental blood showing 
Plasmodium falciparum. An arrow is pointing at P.falciparum in red 
blood cell
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Statistical Package for Social Sciences (SPSS), IBM ver-
sion 20.0. Frequencies and cross-tabulations were used 
to summarize baseline socio-demographic characteris-
tics between mothers with and without placental malaria 
(pm+ and pm−, respectively) and the association of pre-
natal exposure to P. falciparum with socio-demographic 
characteristics was determined using Chi square test. 
Comparison of mean number of clinical malaria epi-
sodes between exposed and unexposed infants was done 
using independent sample t test. The median times from 
birth to first clinical malaria episodes for infants born 
to mothers with placental malaria (exposed) and infants 
born to mothers without placental malaria (unexposed) 
were determined using Kaplan–Meier survival analysis 
and the comparison was carried out using Log rank test. 
Binary logistic regression analysis was used to assess the 
effect of prenatal exposure to P. falciparum on first clini-
cal malaria episode. During the analysis, potential con-
founders were considered into the multivariate model 
and these included gravidity, birth weight, age of mother, 
and infant season of birth. Results were reported as odds 
ratio where applicable with 95 % confidence intervals. A 
‘p’ value of <0.05 was considered to be significant.
Results
Socio‑demographic characteristics of the study population
A total of 206 mother-infant pairs were included in the 
study. Of these, 41 infants were born to pm+ moth-
ers (infants exposed in utero to P. falciparum) and 165 
infants were born to pm− mothers (infants not exposed 
to P. falciparum). Table  1 summarizes the socio-demo-
graphic characteristics of the study population. Of 206 
mothers recruited 66.9 % (n = 76) were primigravida and 
63.1 % (n = 130) were multigravida. Out of 41 mothers 
who had placental malaria, 58.5 % (n = 24) were primi-
gravida while 41.5 % (n = 17) were multigravida, and the 
difference was statistically significant (p  <  0.01). There 
was no statistical significant difference between pm+ 
and pm− mothers on season of birth, level of education 
and age of mother. The use of insecticide treated bed 
nets (ITNs) between exposed infants and unexposed was 
similar (Table  1). The number of infants born with low 
birth weight was significantly higher in infants born to 
pm+ mothers compared to those born to pm− mothers, 
(Table  2) and the difference was statistically significant, 
p = 0.01.
Time to first clinical malaria episode and the mean number 
of clinical malaria episodes
The median time from birth to first clinical malaria epi-
sode in exposed infants was 32  weeks (95  % CI 30.88–
33.12), while in unexposed infants it was 37 weeks (95 % 
CI 35.25–38.75) and the difference in the median time 
was statistically significant (p = 0.003, Fig. 3). The mean 
number of clinical malaria episodes during the first 
2 years of life, among infants born to pm+ mothers was 
0.51 episodes/infant compared to those born to pm− 
mothers with 0.30 episodes/infant and the difference was 
statistically significant (p = 0.038).
The effect of prenatal exposure to Plasmodium falciparum 
on clinical malaria episodes during the first 2 years of life
The effect of prenatal exposure to P. falciparum on clini-
cal malaria episode was assessed using binary logistic 
regression. Important confounding factors included gra-
vidity, season of birth, birth weight of infant, and age 
of mother. The statistical model has shown that fetal in 
utero exposure to P. falciparum is significantly associ-
ated with the vulnerability of infants to clinical malaria 
episodes (Odds Ratio 4.79, 95 % CI 2.21–10.38 p < 0.05) 
while other factors did not statistically influence the clini-
cal malaria episodes in a multivariate analysis (Table 3).
Table 1 Social demographic characteristics of  recruited 
mothers (n = 206)
n(%) represents the numbers of mothers and their percentages in brackets
ITN insecticide treated bed nets, pm− placental malaria negative, pm+ placental 
malaria positive







Primigravida 24 (58.5) 52 (31.5) 0.001
Multigravida 17 (41.5) 113 (68.5)
Marital status
single 8 (19.5) 24 (14.5) 0.3
Married 30 (73.2) 128 (77.6)
Divorced 0 7 (4.2)
Widow 0 3 (1.8)
Cohabiting 3 (7.3) 3 (1.8)
Age of mother (years)
<18 3 (7.3) 13(7.9) 0.9
18–28 24 (58.5) 86 (52.1)
29–39 8 (19.5) 43 (26.1)
40–50 6 (14.6) 22 (13.3)
Use of ITN 41 (100) 165 (100) –
Occupation
Peasant 34 (82.9) 135 (81.8) 0.3
Employed 1 (2.4) 4 (2.4)
Large scale business 0 4 (2.4)
Housewife 5 (12.2) 22 (13.3)
Small scale business 1 (2.4) 0
Education level
Madras 8 (19.5) 36 (21.8) 0.8
Primary school 32 (78.0) 117 (70.9)
Secondary school 1 (2.4) 10 (6.1)
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Discussion
This prospective birth cohort study sought to delineate 
the effect of in utero exposure to P. falciparum infec-
tion on identified indicators of susceptibility, includ-
ing time from birth to first clinical malaria episode and 
mean number of clinical malaria episodes. In addition, 
the effects of other factors that could confound the effect 
of in utero exposure to P. falciparum were also assessed. 
The median time from birth to first clinical malaria epi-
sode was significantly shorter in infants exposed in utero 
to P. falciparum infection than in unexposed infants. 
Clinical malaria infections in both exposed and unex-
posed infants were experienced beyond 6 months of age. 
This finding was corroborated by previous studies, which 
reported that malaria maternal antibodies are protective 
in the first 6 months of infant life [15–17]. The findings in 
this study of the occurrence of first clinical malaria epi-
sodes after 6  months of age in exposed and unexposed 
infants may indicate the possible protection of mater-
nal antibodies as already demonstrated [18]. However, 
the current findings of the time from birth to first clini-
cal malaria episode to be beyond 6 months following the 
waning of maternal antibodies are not consistent with the 
findings of a study done in Cameroon which indicated 
that maternal antibodies were not protective but markers 
of malaria infection [19].
Previous studies demonstrated that prenatal exposure 
to P. falciparum influenced the susceptibility to malaria 
infections by affecting the development of protective 
immunity against malaria infection through develop-
ment of immuno-tolerance to the parasite antigen in 
subsequent malaria infections, rendering the exposed 
infants to be more susceptible to malaria infection than 
the unexposed infants [20]. The current study has dem-
onstrated that infants born to placental malaria-positive 
mothers were more vulnerable and experienced the 
first clinical malaria episode much earlier in life after 
birth than infants born to mothers without placental 
malaria during the first 2 years of life. The other factors 
that could have influenced exposure to malaria infec-
tion, including level of education of the mother and 
use of ITNs, were similar in all recruited mothers and 
were therefore not considered as confounding. How-
ever, the factors which were considered in multivariate 
analysis have shown that, the age of the mother, season 
of birth, weight of infant at birth, and gravidity did not 
affect clinical malaria episodes in the study area. How-
ever, a similar study conducted in Ghana indicated that 
heterogeneity in exposure is likely to be the dominant 
factor influencing incidence of malaria in infancy [21]. 
The findings of the study in Ghana are corroborated by 
studies which have shown that the level of exposure to 
infective Anopheles mosquitoes, the environmental fac-
tors (which may influence mosquito density) and behav-
ioral factors are important in malaria transmission and 
have a direct influence on exposure and susceptibility 
[22, 23].
Although the current study considered some of the fac-
tors which could confound the effect of prenatal exposure 
on susceptibility, it did not incorporate those factors that 
may have a direct influence on exposure to the parasite.
Table 2 Social demographic characteristics of  recruited 
infants (n = 206)
(%) represents the numbers of infants and their percentages in brackets
ITN insecticide treated bed nets, pm− placental malaria negative, pm+ placental 
malaria positive








Infants birth weight (kg)
<2.5 10 (24.4) 16 (9.6) 0.01
≥2.5 31 (75.6) 149 (90.4)
Gender
Female 17 (41.5) 88 (53.3) 0.17
Male 24 (58.5) 77 (46.7)
Season of birth
Dry season 9 (30) 19 (11.5) 0.08
Wet season 32 (70) 146 (88.5)
Use of ITN 41 (100) 165 (100) –
Fig. 3 Kaplan Meier curve showing the survival of infants from birth 
to first clinical malaria episodes between exposed infants and unex-
posed infants. The graph portrays time at first clinical malaria episode 
in pm+ (Bottom green line) and pm− infants (Top blue line)
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Lack of influence of the other exposure-related fac-
tors in this study is supported by the fact that, in the 
study area there was an ongoing anti-malaria campaign 
which involved distribution of ITNs at subsidized cost 
and emphasis was made on use of IPTp-SP for preven-
tion of malaria during pregnancy as part of National 
Malaria Control Programme. The impact of this cam-
paign in the study area was reflected in the general 
malaria prevalence which was reported to be 4.8  % 
[24]. However, the number of mothers with placental 
malaria seemed to remain high (n  =  41) in the per-
ceived context of the effects of placental malaria to the 
exposed infants.
In the present study, the mean number of clinical 
malaria episodes in the first 2  years of life was signifi-
cantly higher in infants exposed to placental malaria than 
unexposed. These findings are corroborated by earlier 
studies, which demonstrated that infants born to pm+ 
mothers were more susceptible to P. falciparum infection 
[25–27].
However, a study done in Ghana indicated that the inci-
dence of malaria in infants born to primigravida without 
placental malaria was significantly lower than that of 
infants born to primigravida with placental malaria but, 
there was no significant difference in the incidence of 
malaria among infants born to multigravida with or with-
out placental malaria [21]. While the findings in infants 
born to primigravida with or without placental malaria 
are consistent with the findings in this study, it is notable 
that the findings in multigravida are not consistent with 
the finding in primigravida, putting into question the 
influence of prenatal exposure to the parasite antigen on 
susceptibility to malaria infection.
In this study, it was noted that a significantly higher 
proportion of primigravida were placental malaria-pos-
itive compared to multigravida (58.5 vs 31.5  %, respec-
tively); hence, the majority of the infants exposed in utero 
to P. falciparum were born to primigravida compared to 
multigravida (24 mothers vs 17 mothers, respectively). 
The increased vulnerability of primigravida to placental 
malaria compared to other gravidities is corroborated by 
a study conducted in Angola [28], which demonstrated 
that primigravida were more susceptible to placen-
tal malaria due to demonstrated low levels of antibod-
ies against chondroitin sulfate A; while these antibodies 
were higher in multigravida [29], which reflected a level 
of protection against placental malaria [30, 31]. It is pos-
sible that the demonstrated high levels of antibodies 
against chondroitin sulfate A in multigravida may have a 
synergistic effect on the protection conferred by maternal 
antibodies to infants born of multigravida. This conjec-
ture is based on findings by a study which demonstrated 
that antibody responses to the N-terminal region of VAR 
2CSA (P. falciparum antigen) during early pregnancy 
Table 3 Effects of prenatal exposure to Plasmodium falciparum, gravidity, Infant birth weight, age of the mother at deliv-
ery, and season of birth to clinical malaria episodes: binary logistic regression
Prenatal exposure to Plasmodium falciparum significantly associated with clinical malaria episodes in univariate and Multivariate analysis (p < 0.01)
OR Odds Ratio, AOR Adjusted Odds Ratio, CI Confidence interval, BLR Binary logistic regression
Factors BLR‑univariate analysis BLR‑multivariate analysis
OR (CI 95 %) p value AOR (CI 95 %) p value
In utero exposure to Plasmodium falciparum
Non-exposure to P. falciparum in utero 1 (–) – 1 (–) –
Exposure to P. falciparum in utero 4.632 (2.248–9.541) p < 0.01 4.791 (2.21–10.38) p < 0.01
Gravidity of mothers
Primigravidity 1 (–) – 1 (–) –
Multigravidity 0.752 (0.4–1.415) 0.372 0.973 (0.475–1.990) 0.939
Infant birth weight
Normal birth weight 1 (–) – 1 (–) –
Low birth weight 0.441 (0.189–1.031) 0.059 0.556 (0.209–1.477) 0.239
Age of mothers (years)
40–50 1 – 1 (–) –
<18 1.833 (0.626–5367) 0.269 2.120 (0.672–6.687) 0.20
18–28 1.100 (0.329–3.677) 0.877 1.196 (0.328–4.361) 0.786
29–39 1.615 (0.779–3.351) 0.198 2.013 (0.913–4.438) 0.083
Infant season of birth
Dry season 1.0 – 1 (–) –
Wet season 0.736 (0.311–1.741) 0.485 0.917(0.338–1.2.484) 0.864
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were associated with reduced risks for infection and low 
birth weight [31].
Although a direct influence of gravidity on susceptibil-
ity was not demonstrated in this study, one study con-
ducted in the northern part of Tanzania showed that 
gravidity interacted with prenatal exposure to malaria 
and played a role in affecting susceptibility of infants to 
malaria infections [32]. This study, demonstrated that 
prenatal exposure to malaria significantly affected the 
susceptibility of infants to first clinical malaria episodes 
in a multivariate analysis, while gravidity did not signifi-
cantly associate with time to first clinical malaria epi-
sode. It is hypothesized that this discrepancy may not 
be inherent to a basic biological or immunological factor 
because being primigravida is a risk to acquiring placen-
tal malaria, which, in essence, may predispose the infant 
to immune-tolerance and, hence, increasing susceptibil-
ity to subsequent malaria infection.
Conclusion
Prenatal exposure to P. falciparum significantly influ-
ences vulnerability to malaria infection. Infants exposed 
in utero to parasite antigens succumb early to clinical 
malaria episodes and experience more frequent clinical 
malaria episodes than unexposed infants during the first 
2 years of life.
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